Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG

The neonatal Fc receptor, (FcRn) is a transmembrane, heterodimeric glycoprotein with a structure similar to MHC class I molecules. In contrast to MHC class I antigens, FcRn does not bind to peptides (antigens) but interacts with the Fc fragment of IgG and albumin. The FcRn-IgG interaction as well as...

Full description

Bibliographic Details
Main Author: Joanna E. Mikulska
Format: Article
Language:English
Published: Index Copernicus International S.A. 2018-07-01
Series:Postępy Higieny i Medycyny Doświadczalnej
Subjects:
IgG
Online Access:http://phmd.pl/gicid/01.3001.0012.2094
id doaj-51d6806a10844d73b63ce3bc17438899
record_format Article
spelling doaj-51d6806a10844d73b63ce3bc174388992020-11-24T20:49:49ZengIndex Copernicus International S.A.Postępy Higieny i Medycyny Doświadczalnej0032-54491732-26932018-07-017270172710.5604/01.3001.0012.209401.3001.0012.2094Neonatal Fc receptor (FcRn) – not only transporter of maternal IgGJoanna E. Mikulska0Instytut Immunologii i Terapii Doświadczalnej PAN im. Ludwika Hirszfelda we WrocławiuThe neonatal Fc receptor, (FcRn) is a transmembrane, heterodimeric glycoprotein with a structure similar to MHC class I molecules. In contrast to MHC class I antigens, FcRn does not bind to peptides (antigens) but interacts with the Fc fragment of IgG and albumin. The FcRn-IgG interaction as well as the FcRn-albumin interaction occur at acidic pH (optimally at pH 5.0-6.5) but not in physiological environment. These two ligands bind to distinct binding sites on the receptor molecule and by different mechanisms. Now, it is known that the expression of FcRn is not restricted to sites involved in the transport of maternal IgG, and this receptor is not responsible only for transfer the passive immunity from mother to the offspring. But FcRn has a much broader range of expression and function, throughout life and in many different cell types and tissues of humans and animals. This review summarizes the status of our knowledge on the expression, interaction with ligands and functions of the neonatal Fc receptor. This article shows also the possibilities of utilizing a current knowledge on FcRn for therapeutic purposes. http://phmd.pl/gicid/01.3001.0012.2094FcRnpromoterIgGalbuminhalf lifeantigen presentation
collection DOAJ
language English
format Article
sources DOAJ
author Joanna E. Mikulska
spellingShingle Joanna E. Mikulska
Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
Postępy Higieny i Medycyny Doświadczalnej
FcRn
promoter
IgG
albumin
half life
antigen presentation
author_facet Joanna E. Mikulska
author_sort Joanna E. Mikulska
title Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
title_short Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
title_full Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
title_fullStr Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
title_full_unstemmed Neonatal Fc receptor (FcRn) – not only transporter of maternal IgG
title_sort neonatal fc receptor (fcrn) – not only transporter of maternal igg
publisher Index Copernicus International S.A.
series Postępy Higieny i Medycyny Doświadczalnej
issn 0032-5449
1732-2693
publishDate 2018-07-01
description The neonatal Fc receptor, (FcRn) is a transmembrane, heterodimeric glycoprotein with a structure similar to MHC class I molecules. In contrast to MHC class I antigens, FcRn does not bind to peptides (antigens) but interacts with the Fc fragment of IgG and albumin. The FcRn-IgG interaction as well as the FcRn-albumin interaction occur at acidic pH (optimally at pH 5.0-6.5) but not in physiological environment. These two ligands bind to distinct binding sites on the receptor molecule and by different mechanisms. Now, it is known that the expression of FcRn is not restricted to sites involved in the transport of maternal IgG, and this receptor is not responsible only for transfer the passive immunity from mother to the offspring. But FcRn has a much broader range of expression and function, throughout life and in many different cell types and tissues of humans and animals. This review summarizes the status of our knowledge on the expression, interaction with ligands and functions of the neonatal Fc receptor. This article shows also the possibilities of utilizing a current knowledge on FcRn for therapeutic purposes.
topic FcRn
promoter
IgG
albumin
half life
antigen presentation
url http://phmd.pl/gicid/01.3001.0012.2094
work_keys_str_mv AT joannaemikulska neonatalfcreceptorfcrnnotonlytransporterofmaternaligg
_version_ 1716805561358483456